Total long-chain polyunsaturated n-3 fatty acids level is an independent predictive factor of breast cancer multifocality in women with positive hormone-receptors tumors.


Journal

Surgical oncology
ISSN: 1879-3320
Titre abrégé: Surg Oncol
Pays: Netherlands
ID NLM: 9208188

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 01 06 2020
revised: 25 04 2021
accepted: 26 04 2021
pubmed: 30 5 2021
medline: 18 1 2022
entrez: 29 5 2021
Statut: ppublish

Résumé

In a previous pilot study, we showed that polyunsaturated n-3 fatty acids of breast adipose tissues were associated with breast cancer multifocality. In the present study, we investigated biochemical, clinical and histological factors associated with breast cancer focality in a large cohort of women with positive hormone-receptors tumors. One hundred sixty-one consecutive women presenting with positive hormone-receptors breast cancer underwent breast-imaging procedures including a Magnetic Resonance Imaging prior to treatment. Breast adipose tissue specimens were collected during surgery of tumors. A biochemical profile of breast adipose tissue fatty acids was established by gas chromatography. Clinicopathologic characteristics were correlated with multifocality. We assessed whether these factors were predictive of breast cancer focality. We found that tumor size (OR = 1.06 95%CI [1.02-1.09], p < 0.001) and decreased levels in breast adipose tissue of long-chain polyunsaturated n-3 fatty acids (OR = 0.11 95%CI [0.01-0.98], p = 0.03), were independent predictive factors of multifocality. Low levels of long chain polyunsaturated n-3 fatty acids in breast adipose tissue appear to contribute to breast cancer multifocality. The present results reinforce the link between dietary habits and breast cancer clinical presentation.

Identifiants

pubmed: 34051659
pii: S0960-7404(21)00086-4
doi: 10.1016/j.suronc.2021.101597
pii:
doi:

Substances chimiques

Fatty Acids, Omega-3 0
Receptors, Estrogen 0
Receptors, Progesterone 0
ERBB2 protein, human EC 2.7.10.1
Receptor, ErbB-2 EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101597

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Lobna Ouldamer (L)

Department of Gynecology, Centre Hospitalier Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044, Tours, France; INSERM UMR1069, 10 boulevard Tonnellé, 37044, Tours, France; Tours University, 10 boulevard Tonnellé, 37044, Tours, France. Electronic address: l.ouldamer@chu-tours.fr.

Caroline Goupille (C)

Department of Gynecology, Centre Hospitalier Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044, Tours, France; INSERM UMR1069, 10 boulevard Tonnellé, 37044, Tours, France; Tours University, 10 boulevard Tonnellé, 37044, Tours, France.

Anne Vildé (A)

Department of Radiology, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, Tours, France.

Flavie Arbion (F)

Department of Pathology, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, Tours, France.

Cyrille Guimaraes (C)

Tours University, 10 boulevard Tonnellé, 37044, Tours, France.

Marie-Lise Jourdan (ML)

INSERM UMR1069, 10 boulevard Tonnellé, 37044, Tours, France; Tours University, 10 boulevard Tonnellé, 37044, Tours, France.

Philippe Bougnoux (P)

INSERM UMR1069, 10 boulevard Tonnellé, 37044, Tours, France; Tours University, 10 boulevard Tonnellé, 37044, Tours, France; Department of Oncology, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, Tours, France.

Gilles Body (G)

Department of Gynecology, Centre Hospitalier Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044, Tours, France; INSERM UMR1069, 10 boulevard Tonnellé, 37044, Tours, France; Tours University, 10 boulevard Tonnellé, 37044, Tours, France.

Stephan Chevalier (S)

INSERM UMR1069, 10 boulevard Tonnellé, 37044, Tours, France; Tours University, 10 boulevard Tonnellé, 37044, Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH